Experimenting with ASL-based arterialized cerebral blood volume as a novel imaging biomarker in grading glial neoplasms.
Krishna Pratap Singh SengerChandrasekharan KesavadasBejoy ThomasAnkita SinghGurpreet Singh MultaniDeepti AnMarc LabelBanerjee SuchandrimaDavid ShinPublished in: The neuroradiology journal (2023)
This study is one of its kind to the best of our knowledge where multi-delay ASL perfusion-derived aCBV is used as a novel imaging biomarker for grading glial neoplasms, and it has shown high statistical correlation with T2* DSC-derived perfusion parameters.